Home Medicine Evaluation of iodine and selenium level and thyroid functions in patients with cystic fibrosis
Article
Licensed
Unlicensed Requires Authentication

Evaluation of iodine and selenium level and thyroid functions in patients with cystic fibrosis

  • Edip Unal ORCID logo EMAIL logo , Enes Arıca ORCID logo , Funda Feryal Taş ORCID logo , Barış Kolbaşı ORCID logo , Nurcan Beyazıt ORCID logo , İbrahim Kaplan ORCID logo , Suat Savaş ORCID logo and Velat Şen ORCID logo
Published/Copyright: January 17, 2025

Abstract

Objectives

There is limited research on thyroid function in pediatric patients with cystic fibrosis (pwCF). This study aimed to determine the frequency of thyroid dysfunction in children and adolescents with CF and to evaluate iodine deficiency and selenium status in pwCF.

Methods

Sixty-two CF patients and 62 control subjects were evaluated. The anthropometric measurements, nutritional status, FEV1(Forced-expiratory-volume in 1 s) percentage, thyroid function tests (TSH, FT4, FT3), urinary iodine and selenium levels, hospitalization status in the last six months, antibiotic usage, and colonization status with staphylococcus or pseudomonas were assessed for the cases.

Results

The mean age of the patient group was 10.84 ± 4.04 years. All CF patients were receiving multivitamin supplementation. Malnutrition was present in 50 % of patients, bacterial colonization in 29 %, FEV1 decrease in 38.5 %, subclinical hypothyroidism (SH) in 12.9 %, iodine deficiency in 87 % and exocrine pancreatic insufficiency in 100 %. T3 levels were found to be higher in pwCF. No significant difference was found between malnutrition and FEV1 and urinary iodine and selenium levels. Compared to the control group, pwCF had lower urinary iodine levels.

Conclusions

To the best of our knowledge, our study is one of the few in the literature to investigate urinary selenium levels alongside iodine in PwCF. Further research is needed to clarify and interpret elevated urinary selenium levels in this context. It was shown that iodine deficiency and the rate of SH were relatively high in pwCF. However, it was still thought that correcting iodine deficiency in these patients could improve thyroid dysfunction associated with CF.


Corresponding author: Edip Unal, MD, Associate Professor of Pediatric Endocrinology, Faculty of Medicine, Department of Pediatric Endocrinology, Dicle University, Diyarbakır, Türkiye, E-mail:

  1. Research ethics: The study was performed in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Dicle University Faculty of Medicine (document number: 25/02/2021/53).

  2. Informed consent: Informed consent was obtained from all individuals included in this study.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interests: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Siwamogsatham, O, Alvarez, JA, Tangpricha, V. Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis. Curr Opin Endocrinol Diabetes Obes 2014;21:422–9. https://doi.org/10.1097/MED.0000000000000096.Search in Google Scholar PubMed PubMed Central

2. Dolan, TFJr, Gibson, LE, Gibson, LE. Complications of iodide therapy in patients with cystic fibrosis. J Pediatr 1971;79:684–7. https://doi.org/10.1016/s0022-3476(71)80324-4.Search in Google Scholar PubMed

3. Segall-Blank, M, Vagenakis, AG, Shwachman, H, Ingbar, SH, Braverman, LE. Thyroid gland function and pituitary TSH reserve in patients with cystic fibrosis. J Pediatr 1981;98:218–22. https://doi.org/10.1016/s0022-3476(81)80638-5.Search in Google Scholar PubMed

4. De Luca, F, Trimarchi, F, Sferlazzas, C, Benvenga, S, Costante, G, Mami, C, et al.. Thyroid function in children with cystic fibrosis. Eur J Pediatr 1982;138:327–30. https://doi.org/10.1007/bf00442510.Search in Google Scholar

5. Azizi, F, Bentley, D, Vagenakis, A, Portnay, G, Bush, JE, Shwachman, H, et al.. Abnormal thyroid function and response to iodides in patients with cystic fibrosis. Trans Assoc Am Phys 1974;87:111–19.Search in Google Scholar

6. Naehrlich, L, Dorr, HG, Bagheri-Behrouzi, A, Rauh, M. Iodine deficiency and subclinical hypothyroidism are common in cystic fibrosis patients. J Trace Elem Med Biol 2013;27:122–5. https://doi.org/10.1016/j.jtemb.2012.08.002.Search in Google Scholar PubMed

7. Giannakopoulos, A, Katelaris, A, Noni, M, Karakonstantakis, T, Kanaka-Gantenbein, C, Doudounakis, S. Hyperthyrotropinemia in newly diagnosed cystic fibrosis patients with pancreatic insufficiency reversed by enzyme therapy. Eur J Pediatr 2018;177:775–9. https://doi.org/10.1007/s00431-018-3120-3.Search in Google Scholar PubMed

8. Zhang, Z, Lai, HJ. Comparison of the use of body mass index percentiles and percentage of ideal body weight to screen for malnutrition in children with cystic fibrosis. Am J Clin Nutr 2004;80:982–91. https://doi.org/10.1093/ajcn/80.4.982.Search in Google Scholar PubMed

9. Miller, MR, Hankinson, J, Brusasco, V, Burgos, F, Casaburi, R, Coates, A, et al.. Standardisation of spirometry. Eur Respir J 2005;26:319–38. https://doi.org/10.1183/09031936.05.00034805.Search in Google Scholar PubMed

10. World Health Organization, UNICEF, Disorders ICfCoID. Assessment of iodine deficiency disorders and monitoring their elimination, 3rd ed. Geneva, Switzerland: World Health Organization; 2007.Search in Google Scholar

11. Wolff, J, Chaikoff, IL, Goldberg, RC, Meier, JR. The temporary nature of the inhibitory action of excess iodine on organic iodine synthesis in the normal thyroid. Endocrinology 1949;45:504–13, illust. https://doi.org/10.1210/endo-45-5-504.Search in Google Scholar PubMed

12. Bath, SC, Verkaik-Kloosterman, J, Sabatier, M, Ter Borg, S, Eilander, A, Hora, K, et al.. A systematic review of iodine intake in children, adults, and pregnant women in Europe-comparison against dietary recommendations and evaluation of dietary iodine sources. Nutr Rev 2022;80:2154–77. https://doi.org/10.1093/nutrit/nuac032.Search in Google Scholar PubMed PubMed Central

13. Knopfle, G. The thyroid hormone system in mucoviscidosis. Klin Pädiatr 1985;197:481–8. https://doi.org/10.1055/s-2008-1034026.Search in Google Scholar PubMed

14. Lee, SY, Chesdachai, S, Lee, MJ, He, XM, Tangpricha, V, Braverman, LE. Thyroid function in patients with cystic fibrosis: No longer a concern? Thyroid 2016;26:875–9. https://doi.org/10.1089/thy.2015.0567 [Epub 2016 May 19].Search in Google Scholar PubMed PubMed Central

15. Volta, C, Street, ME, Ziveri, MA, Bonelli, P, Spaggiari, C, Grzincich, GL, et al.. Thyroid function, cytokine and IGF-IGFBP interactions in cystic fibrosis patients. Horm Res 2005;63:206–10. https://doi.org/10.1159/000085839.Search in Google Scholar PubMed

16. Sack, J, Blau, H, Amado, O, Katznelson, D. Thyroid function in cystic fibrosis patients compared with healthy Israeli children. Isr J Med Sci 1983;19:17–19.Search in Google Scholar

17. Zimmermann, MB, köhrle, J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002;12:867–78. https://doi.org/10.1089/105072502761016494.Search in Google Scholar PubMed

18. Fairweather-Tait, SJ, Bao, Y, Broadley, MR, Collings, R, Ford, D, Hesketh, JE, et al.. Selenium in human health and disease. Antioxidants Redox Signal 2011;14:1337–83. https://doi.org/10.1089/ars.2010.3275.Search in Google Scholar PubMed

19. Longnecker, MP, Stram, DO, Taylor, PR, Levander, OA, Howe, M, Veillon, C, et al.. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 1996;7:384–90. https://doi.org/10.1097/00001648-199607000-00008.Search in Google Scholar PubMed

20. Yang, G, Zhou, R, Yin, S, Gu, L, Yan, B, Liu, Y, et al.. Studies of safe maximal daily dietary selenium intake in a seleniferous area in China. I. Selenium intake and tissue selenium levels of the inhabitants. J Trace Elem Electrolytes Health & Dis 1989;3:77–87.Search in Google Scholar

21. Mutonhodza, B, Dembedza, MP, Joy, EJM, Manzeke-Kangara, MG, Njovo, H, Nyadzayo, TK, et al.. Urine Se concentration poorly predicts plasma Se concentration at sub-district scales in Zimbabwe, limiting its value as a biomarker of population Se status. Front Nutr 2024;11:1288748. https://doi.org/10.3389/fnut.2024.1288748. eCollection 2024.Search in Google Scholar PubMed PubMed Central

Received: 2024-11-26
Accepted: 2025-01-06
Published Online: 2025-01-17
Published in Print: 2025-03-26

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Thyroid surgery in pediatric age: a 10-year experience at a single center and literature review
  4. Differentiated thyroid cancer in adolescents – does extent of disease at presentation differ with age?
  5. Evaluation of iodine and selenium level and thyroid functions in patients with cystic fibrosis
  6. Interpreting positive celiac serology in children with new-onset type 1 diabetes
  7. Elastographic evaluation for fatty liver disease in north Indian children and adolescents with type 1 diabetes
  8. Diagnostic value of fasting insulin and insulin-like growth factor-1 levels in girls with central precocious puberty
  9. Clinical outcomes of switching to lonapegsomatropin from somatropin for treatment of pediatric growth hormone deficiency
  10. Development of a disease diagnostic model to predict the occurrence of central precocious puberty of female
  11. Adrenal hypoandrogenism in adolescents with premature ovarian insufficiency
  12. The clinical presentation and genetic diagnosis of Tangier disease in the pediatric age group
  13. Clinical and genetic diagnosis of first cohort of differences of sexual development in the Iranian population
  14. Short Communication
  15. Effect of a GnRH injection on kisspeptin levels in girls with suspected precocious puberty: a randomized-controlled pilot study
  16. Case Reports
  17. Coexistence of phenylketonuria and tyrosinemia type 3: challenges in the dietary management
  18. Acrodermatitis dysmetabolica: lessons from two pediatric cases
  19. Dramatic response to Evinacumab in a North Indian girl with homozygous familial hypercholesterolemia
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2024-0566/pdf
Scroll to top button